Initial Treatment of Idiopathic Nephrotic Syndrome in Children with Mycophenolate Mofetil vs. Prednisone: A Prospective, Randomized, Controlled, Multicenter, Open, Phase 3, Noninferiority Study

被引：0

作者：

Benz, Marcus R. ^{[1
,2
]}

Ehren, Rasmus ^{[1
]}

Hoecker, Britta ^{[3
]}

Fichtner, Alexander ^{[3
]}

Querfeld, Uwe ^{[4
]}

Hoyer, Peter F. ^{[5
]}

Kemper, Markus J. ^{[6
]}

Haffner, Dieter ^{[7
]}

Dotsch, Joerg ^{[1
]}

Konrad, Martin ^{[8
]}

Sander, Anja Christine ^{[9
]}

Meis, Jan ^{[9
]}

Toenshoff, Burkhard ^{[3
]}

Weber, Lutz Thorsten ^{[1
]}

机构：

[1] Univ Hosp Cologne, Cologne, Germany

[2] Pediat Nephrol Dachau, Dachau, Germany

[3] Univ Childrens Hosp Heidelberg, Heidelberg, Germany

[4] Charite Univ Med Berlin, Berlin, Germany

[5] Univ Duisburg Essen, Duisburg, Nordrhein Westf, Germany

[6] Asklepios Kliniken GmbH & Co KGaA, Hamburg, Germany

[7] Med Hsch Hannover Zentrum Kinderheilkunde & Jugen, Hannover, Niedersachsen, Germany

[8] Univ Munster, Munster, Nordrhein Westf, Germany

[9] Heidelberg Univ, Heidelberg, Baden Wurttembe, Germany

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期

关键词：

D O I：

10.1681/ASN.2024dxr49rap

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-OR74

引用

页数：2

共 50 条

[41] A phase 3, multicenter, open, randomized controlled clinical study of gemcitabine plus capecitabine versus gemcitabine plus carboplatin in the first-line treatment for advanced triple-negative breast cancer.
Liu, Xiaodong
Zhao, Weipeng
Jia, Yongsheng
Shi, Yehui
Wang, Xu
Li, Shufen
Wang, Chen
Hao, Chunfang
Tong, Zhongsheng
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[42] A Multicenter Phase II Rater-Blinded Randomized Controlled Trial to Compare the Effectiveness of Eye Movement Desensitization Reprocessing Therapy vs. Treatment as Usual in Patients With Substance Use Disorder and History of Psychological Trauma: A Study Design and Protocol
Valiente-Gomez, Alicia
Moreno-Alcazar, Ana
Radua, Joaquim
Hogg, Bridget
Blanco, Laura
Lupo, W.
Perez, Victor
Robles-Martinez, Maria
Torrens, Marta
Amann, Benedikt L.
FRONTIERS IN PSYCHIATRY, 2019, 10
[43] Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021
Tap, W.
Papai, Z.
van Tine, B.
Attia, S.
Ganjoo, K.
Jones, R. L.
Schuetze, S.
Reed, D.
Chawla, S. P.
Riedel, R.
Krarup-Hansen, A.
Italiano, A.
Hohenberger, P.
Grignani, G.
Cranmer, L.
Alcindor, T.
Lopez-Pousa, A.
Pearce, T.
Kroll, S.
Schoffski, P.
ANNALS OF ONCOLOGY, 2016, 27
[44] LUX-LUNG 3: A RANDOMIZED, OPEN-LABEL, PHASE III STUDY OF AFATINIB VS. PEMETREXED AND CISPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE LUNG HARBORING EGFR ACTIVATING MUTATIONS
O'Byrne, Ken
Schuler, Martin
Yamamoto, Nobuyuki
Hirsh, Vera
Mok, Tony
Massey, Dan
Zazulina, Victoria
Shahidi, Mehdi
Sequist, Lecia
Yang, James
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S102 - S102
[45] A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting
Deeb, Larry C.
Dulude, Helene
Guzman, Cristina B.
Zhang, Shuyu
Reiner, Barry J.
Piche, Claude A.
Pradhan, Sheetal
Zhang, Xiaotian Michelle
PEDIATRIC DIABETES, 2018, 19 (05) : 1007 - 1013
[46] Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenstrom's Macroglobulinemia (MW): Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)
Rummel, Mathias J.
Lerchenmueller, Christian
Hensel, Manfred
Goerner, Martin
Buske, Christian
Schulz, Holger
Schmidt, Burkhard
Kojouharoff, Georgi
Lange, Elisabeth
Willenbacher, Wolfgang
Durig, Jan
Engel, Erik
Kauff, Frank
Barth, Jurgen
Burchardt, Alexander Christoph
Hinke, Axel
Wupperfeld, Jasmin
Greil, Richard
BLOOD, 2019, 134
[47] Initial Report of a Large, Randomized, Double Blind, Placebo-controlled, Phase 3 Trial of Terlipressin plus Albumin for the Treatment of Type 1Hepatorenal Syndrome (HRS-1): The REVERSE Study
Boyer, Thomas D.
Sanyal, Arun J.
Wong, Florence
Frederick, R. Todd
Lake, John R.
O'Leary, Jacqueline G.
Ganger, Daniel
Box, Terry D.
Jamil, Khurram
Pappas, Stephen Chris
HEPATOLOGY, 2014, 60 : 255A - 255A
[48] The CLEAR Study: A Prospective, Randomized, Controlled, Open-Label, Multicentre 6-Month Study Comparing the Efficacy and Safety of a 5-Day 3-g Daily Mycophenolate Mofetil (MMF) Loading Dose Versus Standard 2-g MMF Daily Dosing in Renal Allograft Transplant Recipients.
Gourishankar, Sita
Houde, Isabelle
Keown, Paul
Wrobel, Michelle
Kiberd, Bryce
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 219 - 219
[49] VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of 177Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).
Sartor, A. Oliver
Morris, Michael J.
Krause, Bernd J.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[50] Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia
Mesa, Ruben A.
Komatsu, Norio
Gill, Harinder
Jin, Jie
Lee, Sung-Eun
Hou, Hsin-An
Sato, Toshiaki
Qin, Albert
Urbanski, Raymond
Shih, Weichung
Zagrijtschuk, Oleh
Zimmerman, Craig
Verstovsek, Srdan
BLOOD, 2021, 138

← 1 2 3 4 5 →